Weight loss

This special episode of 5ive Live covers major developments across environmental policy, business, public health, and state politics.

Speaking at the India Today HealthWealth Summit, Dr Isaac Mathai and Dr Sudhindra Uppoor discussed preventive healthcare, fasting, food habits, sleep and traditional medicine. They also shared their views on Panchakarma and the growing use of GLP-1 weight-loss drugs.

Indian benchmark equity indices registered an eighth consecutive week of losses, marking their longest weekly losing streak in 25 years. The BSE Sensex settled near 71,910 while the NSE Nifty traded around 22,420, erasing six lakh crore rupees in investor wealth and turning financial year returns negative. Market weakness was driven by elevated global bond yields, foreign portfolio outflows, and geopolitical conflict in West Asia. Sectoral declines affected auto, FMCG, metals, and infrastructure, while information technology and private banking stocks showed relative stability. In the energy sector, Indian Oil Corporation procured two million barrels of Iraqi Basrah medium crude at a 32-dollar per barrel discount amid transit disruptions through the Strait of Hormuz. Additionally, global pharmaceutical firms Novo Nordisk and Eli Lilly are progressing regulatory clearances for oral GLP-1 weight-loss medications in India by 2027, while airline operator KLM highlighted India's scope to manufacture sustainable aviation fuel.

Stock markets faced downward pressure as rising crude oil prices and simmering US-Iran tensions weighed on investor sentiment, dragging Nifty down to 23,779 amid steep declines in IT and metal shares. In corporate developments, Jaguar Land Rover announced 4,000 job cuts in the UK over two years to save 2.3 billion dollars amid tariff pressures and cyberattack impacts. Meanwhile, the domestic pharmaceutical sector witnessed robust momentum driven by weight loss and diabetes treatments, with Eli Lilly's Mounjaro recording over 500 percent sales growth and RPG Life Sciences preparing to launch its GLP-1 drug. Ashok Leyland highlighted strong growth in defense, with revenues tripling to over 1,200 crore rupees alongside a new production facility planned in Saudi Arabia. Market expert Abhishek Basumallik shared an optimistic outlook on the pharmaceutical and chemical sectors while advising caution regarding cyclical peaks in the automotive space and evaluating the surge of new public offerings.

This News Today edition covers the 25th day of Sonam Wangchuk's hunger fast over examination paper leaks. Speaking from Medanta Hospital, his wife confirmed an 11-kilo weight loss, stating the fast will continue until demands, including the Union Education Minister’s resignation and education reforms, are met. The government agreed to parliamentary discussions but refused the resignation.

Less than twenty-four hours to go for the ceasefire deadline between the United States and Iran to end, but uncertainty looms over the second round of talks in Islamabad.

Gurugram drug controller officers intercepted a car in DLF Phase IV, seizing fake Mounjaro injections worth nearly fifty-six lakh rupees. The counterfeit weight loss and diabetes drugs lacked proper cold chain storage and licenses, leading to the arrest of two men.

This special edition of Health 360 highlights several pressing medical and lifestyle concerns, starting with the alarming trend of brides using diabetes medications for rapid cosmetic weight loss before their weddings.

An India Today investigation on Health 360 explores how early signs of Parkinson's disease may appear years before diagnosis through subtle symptoms like constipation, reduced sense of smell, mood disturbances and disrupted sleep.

A new episode of Doctor vs Internet takes a closer look at the growing buzz around weight-loss injections, as experts warn against blindly following trends without understanding the science behind them. Hosted by Sonal Mehrotra Kapoor, the episode features Mumbai-based endocrinologist Dr Shashank Joshi, who breaks down the rise of GLP-1 drugs and their role in treating obesity. He explains who should consider these injections, the different types available, and why medical supervision is essential. The discussion also turns to what experts call the “thin-fat Indian” profile, where people may appear lean but have high body fat and metabolic risks. Dr Joshi links this to genetic factors and lifestyle patterns, saying obesity is not simply about diet or exercise alone. He cautions against the misuse of GLP-1 drugs without prescription, warning of potential health risks. The episode also stresses the importance of building muscle for long-term health and questions some traditional food practices that may reduce nutritional value. The conversation aims to help viewers make informed decisions as weight-loss treatments become increasingly popular.

India's obesity drug market is entering a new phase as Novo Nordisk's key semaglutide patent expires, allowing Indian pharmaceutical companies to launch lower-cost versions of the active ingredient used in Ozempic and Wegovy.

The patent for Semaglutide, the active ingredient in blockbuster weight-loss drugs like Ozempic and Wegovy, expired on March 20, triggering a dramatic price crash in India.

Speaking at the India Today Conclave in Delhi, robotic GI surgeon Dr Anshuman Kaushal, popularly known as ‘Angry Doc’, explains how AI is reshaping healthcare from robotic surgery to diagnostics while stressing that doctors will remain vital for judgement, empathy and patient trust.

In this episode of 5 Live, the focus is on Prime Minister Narendra Modi's historic 2-day Israel visit. 

In this episode of Health360, host Sneha Mordani explores critical health updates, starting with a Lancet report revealing that 40% of Indians suffer from non-alcoholic fatty liver disease (NAFLD).

A recent study reveals that while 84% of Indians have attempted to lose weight at some point in time, only 4.7% managed to sustain even modest weight loss for a year.

In a tragic hit-and-run incident in Lucknow, a 21-year-old Class 12 student, Gaurav Singh, was detained after his speeding car rammed into multiple people, resulting in the death of a six-year-old child and injuring four people.

In this episode of 5 Live, watch an India Today special investigation that exposed the unauthorised sale of GLP-1 weight loss injections, including Mounjaro, Wegovy, and Ozempic, in chemist shops and online in Delhi-NCR.

A recent Super Bowl commercial featuring tennis legend Serena Williams has sparked a significant debate regarding the ethical implications of celebrity endorsements for prescription weight-loss medications.

This episode of 5 Live highlights the financial struggles of Rajasthan's medal-winning athletes, including Asian Games medallist Rakesh and national record holder Neeraj Kumar.